NICE appraisals should be everybody's business.
Where this comes from
- Record sourced from PubMed, PMID 17478847.
- Also identified by PMC identifier 1865413.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When Newbury and Community Primary Care Trust appealed against NICE's decision on Herceptin, it was the first to do so. <b>Jane Wells</b> and <b>Claire Cheong-Leen </b>explain the process and why other trusts should make their voices heard in appraisals of new treatments
Medical subject headings
- Drug Approval
- Government Agencies
- State Medicine
- Technology Assessment, Biomedical